Eggshell membrane as promising supplement to maintain bone health: A systematic review.
Bone density
Bone mineralization
Collagen type I
Glycosaminoglycans
Journal
Bone reports
ISSN: 2352-1872
Titre abrégé: Bone Rep
Pays: United States
ID NLM: 101646176
Informations de publication
Date de publication:
Jun 2024
Jun 2024
Historique:
received:
05
02
2024
revised:
14
05
2024
accepted:
21
05
2024
medline:
14
6
2024
pubmed:
14
6
2024
entrez:
14
6
2024
Statut:
epublish
Résumé
Bone loss is a well-known phenomenon in the older population leading to increased bone fracture risk, morbidity, and mortality. Supplementation of eggshell membrane (ESM) is evaluated due to its possible application to prevent bone loss and usage in osteoporosis therapy. The similar organic chemical composition of ESM and human bone is described in detail as both mainly consist of collagen type I, chondroitin sulfate, dermatan sulfate, hyaluronic acid and elastan. ESM and its components are reported to improve mineralization in bone tissue. In many studies ESM intake reduced pain in patients with joint disorders and reduced inflammatory processes. Additionally, ESM improved calcium uptake in human cells. These findings in comparison with a clinical pilot study reporting pain reduction in osteoporotic patients and increased osteoblast activity in in vitro assays support ESM to be a beneficial supplement for bone health. In this systematic review we combined chemical structure analysis with clinical studies to give a more comprehensive picture with novel explanations.
Identifiants
pubmed: 38872992
doi: 10.1016/j.bonr.2024.101776
pii: S2352-1872(24)00043-3
pmc: PMC11170356
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
101776Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
JPF reported receiving personal fees from Apomedica Pharmazeutische Produkte GmbH as employee.The authors have no conflict of interest to declare.